The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical utility of reporting research genetic predisposition testing results to Total Cancer Care participants.
 
Megan Leigh Hutchcraft
No Relationships to Disclose
 
Shulin Zhang
No Relationships to Disclose
 
Nan Lin
No Relationships to Disclose
 
Justine C Pickarski
No Relationships to Disclose
 
Sainan Wei
No Relationships to Disclose
 
Rachel W. Miller
No Relationships to Disclose
 
John L. Villano
No Relationships to Disclose
 
Michael J. Cavnar
No Relationships to Disclose
 
Joseph Kim
Research Funding - Exelixis/Ipsen (Inst); Merck (Inst)
 
Susanne M. Arnold
Consulting or Advisory Role - Penn State Cancer Institute
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Ellipses Pharma (Inst); Exelixis (Inst); Gilead Sciences (Inst); Incyte (Inst); Kinnate Biopharma (Inst); Kura Oncology (Inst); LabCorp (Inst); Merck Sharp & Dohme (Inst); National Cancer Institute (Inst); Nektar (Inst); Ohio State University (Inst); Regeneron (Inst); Syneos Health (Inst)
 
Frederick R Ueland
No Relationships to Disclose
 
Jill Kolesar
Stock and Other Ownership Interests - Helix Diagnostics
Consulting or Advisory Role - The Jackson Laboratory
Research Funding - ArtemiLife; Loxo/Lilly (Inst)
Patents, Royalties, Other Intellectual Property - Patent pending for a cell based therapy derived from human macrophages
Travel, Accommodations, Expenses - Caris Life Sciences